Roche Opens Pharma R & D Center in Basel to advance scientific innovation

Roche announced the establishment of its new Pharma Research and Early Development (pRED) Center located at its global headquarters in Basel, Switzerland. With state-of-the-art technologies and approximately 1,000 advanced laboratory and office spaces, the new facility gathers scientists and researchers to speed up medical advancements for patients.

Severin Schwan, Chairman of the Roche Group: “Roche has invested CHF 1.2 billion into the new pRED Center, underscoring our ongoing commitment to supporting Switzerland in remaining a leading innovative life sciences hub, the country where Roche was founded over 125 years ago.”

Thomas Schinecker, CEO of the Roche Group: “The new pRED Center will play an integral role in collaborating with our research centers across the globe, aiming to boost the effectiveness and efficiency of our R&D, and to deliver the greatest impact for patients.”

Hans Clevers, Head of Pharma Research and Early Development (pRED): “By investing in the new center we are continuing to push scientific frontiers to translate innovation into medicines, to better meet the needs of our patients. The new center will enable greater interaction and knowledge sharing across disciplines, for example, chemists, biologists and data scientists.”

Established in Basel, Switzerland in 1896, Roche started as one of the initial industrial producers of branded medications and has since become the top biotechnology company worldwide, as well as the leader in in-vitro diagnostics.